Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.

Risk stratification used a validated 5-year absolute risk calculator incorporating breast density, family history, biopsy history, race/ethnicity, and menopausal status, with reassessment every five ...

Longevity Medical Institute® today announced the launch of its AI-enhanced full-body MRI program, the first of its kind in Los Cabos, Mexico expanding the Institute's advanced diagnostic capabilities ...